Synopsis
MHRA guidance on its assessment of non-clinical data generated outside OECD system MHRA issues new guidance on its approach to clinical trial applications that rely on non-clinical safety data generated outside the OECD Mutual Acceptance of Data system.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at MHRA (UK medicines regulator) ↗